Articles

Poll

Podcasts

Slideshows

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

A new study utilizing machine learning reveals how physical activity reduces gout risk in people with hyperuricemia.

Physical Activity and Sedentary Time Top Factors for Gout Risk in People With Hyperuricemia

A recent study reveals a significant prevalence of gout in end-stage renal disease patients, highlighting the complex relationship between kidney function and uric acid levels.

Gout Prevalence High Among Patients With End-Stage Real Disease 

Pegloticase treatment significantly improves serum urate levels and quality of life in kidney transplant recipients with gout, showing promising clinical benefits.

Pegloticase Managed Gout, Improved QoL Measures in Kidney Transplant Recipients

Febuxostat was associated with a nearly 3-fold higher risk of mild to moderate perturbation of liver function than benzbromarone.

Higher Hepatotoxicity Risk With Febuxostat Over Benzbromarone in People With Gout

Significant associations were seen in males, Mexican Americans, married individuals, those with insufficient physical activity, and those with diabetes. 

Monocyte-to-HDL-C Ratio Correlated With Gout Risk and Renal Injury 

More studies are needed to assess whether creatinine or and hyperuricemia may be prognostic factors for these patients.

Creatinine Predicts Hyperuricemia in Patients With Breast Cancer

Dual-energy computed tomography results in faster dissolution of both the core and crown of tophi.

Research Shows Ultrasound Less Effective than DECT at Removing Tophi

Despite common practice avoiding benzbromarone, new data suggest it has a relatively low hepatotoxicity versus its more common counterpart in gout.

Febuxostat More Hepatotoxic than Benzbromarone in Gout, Study Finds

Our Q1 2025 recap for rheumatology spotlights 5 regulatory updates, 5 key trial announcements, and top expert perspectives in rheumatology care.

Q1 2025 Recap: Rheumatology News and Updates

The rheumatology month in review emphasizes new research in gout, fibromyalgia, and psoriatic arthritis.

Rheumatology Month in Review: April 2025

On the HCPLive gout page, resources on the topics of medical news and expert insight into gouty arthritis can be found. Content includes articles, interviews, videos, podcasts, and breaking news on gout, and more.